May 2022 – For patients facing a terminal cancer diagnosis, this question is critically important. But most of the time, patients don’t get a straight answer.

view article

March 2021 – This is the first international survey completed with the purpose of identifying brain tumour patient and caregiver concerns due to COVID-19.

view article

February 2021 – An international multidisciplinary consortium, co-led by the European Organization for Research and Treatment of Cancer (EORTC) and Boehringer Ingelheim (BI), has been convened to generate recommendations to standardize the use, analysis, and interpretation of patient reported outcome (PRO) data in cancer clinical trials.

view article

May 2020 – For the past 70 years, the best indicator of life expectancy for a patient with glioblastoma (GBM) — the most common and the most aggressive brain cancer — has simply been age at diagnosis.

view article

August 2019

view article